ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke (EUREKA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01364220
Recruitment Status : Terminated (Slow enrollment)
First Posted : June 2, 2011
Last Update Posted : November 20, 2014
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Ji Hoe Heo, Severance Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : April 2013